Iqos Heets USA sales admission analysis
IQOS is a tobacco heating system, an alternative to cigarettes. Unlike regular cigarettes, tobacco in IQOS does not burn, but heats up. In the United States, there was a strict Iqos Heets USA sales admission procedure.
The sticks contain tobacco and nicotine. The device is intended for adult smokers who do not intend to quit the habit, but are looking for another alternative to cigarettes.
In October this year, IQOS sales officially started in the UnitedStates after the Iqos Heets USA sales admission procedure. The brand’sfirst store opened in Atlanta, and about 500 retailers began selling IQOS and sticks in their stores.
IQOS is the world’s first electronic tobacco heating system to be sold in the United States after the strict Iqos Heets USA sales admission procedure. Until this point, the market for electronic devices for smokers was limited to vapes and e-cigarettes.
In the field of quality standards, the most principled and meticulous inspection body is the American FDA (Food & Drug Administration).
This government agency is responsible for quality control of food, medicine, tobacco, veterinary products, and animal feed in the United States. The influence of the FDA is so great that in many countries, governments rely on their recommendations.
Each manufacturer of goods from these categories goes through the same procedure: submits an application, which is considered by an authorized committee of the FDA. The time for consideration of the application is not limited and depends on the complexity and novelty of the product. The country of production does not matter – equally strict standards are applied to all, national companies have no advantages.
The FDA, at its discretion, asks manufacturers for missing information, initiates consultations with independent experts, or conducts its own research. And only being convinced of the quality and safety of the product, the FDA makes a decision on admission to sale.
The IQOS application was reviewed by the FDA for 2 years. During this time, the FDA’s Tobacco Product Committee conducted several of its own studies and also requested additional data from Philip Morris International.
On April 30, 2019, the FDA made an official statement: “FDA permits sale of IQOS tobacco heating system” (that is, the FDA authorizes the sale of the IQOS tobacco heating system). The FDA press release on the authorization to sell IQOS in the United States is published on the
organization’s official website.